Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors (PACHA)
Breast Neoplasms, Breast Cancer
About this trial
This is an interventional supportive care trial for Breast Neoplasms focused on measuring Breast Cancer, Adjuvant Endocrine Therapy, Adherence to Treatment, Community Pharmacy, Support, Survivorship, Intervention Evaluation, Pilot Study, Randomized Controlled Trial, Feasibility Study, Mixed-Methods
Eligibility Criteria
Inclusion Criteria: For pharmacies : In the province of Quebec, Canada At least one pharmacist agrees to take charge of the project in their pharmacy At least one women has initiated adjuvant endocrine therapy (AET) in the last 6 months in the pharmacy For pharmacists : Practicing in a pharmacy in the province of Quebec Provide consent For women : 18 years old or older Were diagnosed with a first non-metastatic, hormone-sensitive breast cancer Received and AET prescription for the first time in the last 6 months Are fluent in French Agree to continue being followed by their current pharmacy for the duration of the study Have internet access Provide consent Exclusion Criteria: For women : • Live in a residential facility where AET is not self-managed
Sites / Locations
- Centre de recherche du CHU de QuébecRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
PACHA program group
Usual care group
Pharmacists and women in the PACHA program group will receive the PACHA program component's.
Pharmacists and women in the Usual care group will provide/receive usual care.